~~<i id='155A830AEB'><strike id='155A830AEB'><tt id='155A830AEB'><pre id='155A830AEB'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

explore

author：comprehensive 2025-09-29 16:35:27 - browse：8

Damian Garde of STAT talks with Liisa Bayko of Evercore ISI and Jared Holz of Mizuho at STAT in NYC. — Damian Garde of STAT, left, talked with Liisa Bayko of Evercore ISI and Jared Holz of Mizuho about the GLP-1 weight loss market. Michelle C. Gevint for STAT

NEW YORK — Will the world actually soon spend $100 billion a year on the new obesity medicines?

Plenty of people in pharma and at the banks that invest in it seem to think so. Goldman Sachs, Barclays, BMO Capital Markets and Pfizer have all arrived at the glossy, cut-for-headline number for spending by around 2030.

Yet Jared Holz, a healthcare strategist at Mizuho, is skeptical.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： Readers discuss the intersection of pregnancy and addiction

hotspot

knowledge

entertainment

focus

hotspot

leisure time

3:08TravelerscheckthestatusoftheirflightsaheadoftheJuly4holidayweekendatRonaldReaganWashingtonNation

WSS

Couple fighting to bring baby home from Mexico are finally reunited

No Labels group has 'steep climb,' but third party 'worth trying': Larry Hogan

Stanford president to resign after investigation of research

Pharma companies must ensure equitable access to obesity drugs

States increasingly look to regulate hospital facility fees

Lindsay Lohan welcomes 1st child with husband Bader Shammas

explore

explore

hotspot

Drug repurposing or repositioning? The language matters

Researchers separate signal from noise in heart wearable data

Bright Health sells Medicare Advantage business to Molina

ALS patient reclaims some autonomy thanks to wearable 'robot'

Heart attack and stroke risk calculators need revising

How dance can help health care workers heal from trauma

George Santos makes 1st court appearance after pleading not guilty to 13 counts

'Essentially witchcraft:' A former naturopath takes on the field

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Curing rare childhood diseases will falter unless Congress steps up

knowledge

Actors' union, Hollywood studios squabble over which side to blame as strike enters 5th day

STAT's 2023 biotech VC rankings: ARCH Venture Partners tops list

Norman Reedus' Daryl Dixon

How faith leaders like me can help address America's obesity epidemic

Celebrate National Dole Whip Day for 3 days this week at Disney

Couple fighting to bring baby home from Mexico are finally reunited

entertainment

focus

hotspot

leisure time